0001127602-18-033265.txt : 20181115
0001127602-18-033265.hdr.sgml : 20181115
20181115204507
ACCESSION NUMBER: 0001127602-18-033265
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181114
FILED AS OF DATE: 20181115
DATE AS OF CHANGE: 20181115
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grossi Federico
CENTRAL INDEX KEY: 0001720634
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 181188496
MAIL ADDRESS:
STREET 1: C/O APELLIS PHARMACEUTICALS, INC.
STREET 2: 6400 WESTWIND WAY, SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
BUSINESS PHONE: 502-241-4114
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-11-14
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001720634
Grossi Federico
C/O APELLIS PHARMACEUTICALS, INC
6400 WESTWIND WAY, SUITE A
CRESTWOOD
KY
40014
1
See Remarks
Common Stock
2018-11-14
4
M
0
6250
3.20
A
22456
D
Stock Option (Right to Buy)
3.20
2018-11-14
4
M
0
6250
0
D
2024-12-11
Common Stock
6250
55573
D
This option was granted on December 12, 2014 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
2018-11-15